Teva Medical Expert, MD
Teva Branded Pharmaceutical Products R&D LLC · Teva Branded Pharmaceutical Products R&D, Inc. · Teva Pharmaceuticals Development, Inc.
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Teva Medical Expert, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:32 UTC. Open this list on ClinicalTrials.gov
- Ph2/Ph3NCT07920211 · Two Trials to Evaluate TEV-53408 in Participants With Non-Segmental VitiligoTeva Branded Pharmaceutical Products R&D LLC · not yet recruiting · Vitiligo · study director
- N/ANCT07913100 · Real-World Impact of TV-44749 in Adults With SchizophreniaTeva Branded Pharmaceutical Products R&D LLC · not yet recruiting · Schizophrenia · study director
- Ph1NCT07674940 · A Trial to Assess TEV-56286 at Different Doses in Healthy ParticipantsTeva Branded Pharmaceutical Products R&D LLC · recruiting · Healthy Volunteers · study director
- Ph4NCT07601516 · Real World Effectiveness and Safety of Deutetrabenazine in Adult Chinese Participants With Huntington's Disease (HD) Chorea in ChinaTeva Branded Pharmaceutical Products R&D LLC · completed · Huntington's Disease, Chorea · study director
- Ph2NCT07197866 · An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple System AtrophyTeva Branded Pharmaceutical Products R&D LLC · recruiting · Multiple System Atrophy · study director
- Ph1NCT06911567 · A Study to Assess New Formulations of TEV-56286Teva Branded Pharmaceutical Products R&D LLC · completed · Healthy Participants · study director
- Ph2NCT06807463 · A Trial to Assess the Efficacy and Safety of TEV-53408 in Adults With Celiac DiseaseTeva Branded Pharmaceutical Products R&D LLC · active not recruiting · Celiac Disease · study director
- Ph3NCT06664619 · A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With AsthmaTeva Branded Pharmaceutical Products R&D LLC · completed · Asthma · study director
- Ph1NCT06627231 · Mass Balance Clinical Trial With TEV-56286Teva Branded Pharmaceutical Products R&D, Inc. · completed · Healthy Participants · study director
- Ph1NCT06625177 · A Trial to Test the Safety and Efficacy of TEV-53408 in Participants With VitiligoTeva Branded Pharmaceutical Products R&D LLC · recruiting · Vitiligo · study director
- Ph1NCT06480552 · An Open-label Dose Escalation/Expansion Trial to Evaluate the Safety and Anti-tumor Activity of TEV-56278 Alone or in Combination With Pembrolizumab in Participants With Advanced or Metastatic Solid TumorsTeva Branded Pharmaceutical Products R&D LLC · recruiting · Advanced Solid Tumors · study director
- Ph1NCT06319170 · Open-label Trial Characterizing the PK of 3 SC Olanzapine Extended-release Formulations in Participants With Schizophrenia/Schizoaffective DisorderTeva Branded Pharmaceutical Products R&D LLC · completed · Schizophrenia, Schizoaffective Disorder · study director
- Ph1NCT06315283 · An Open-Label Trial to Assess the Comparative Bioavailability of TV-44749 to Oral Olanzapine in Participants With SchizophreniaTeva Branded Pharmaceutical Products R&D LLC · completed · Schizophrenia · study director
- Ph1NCT06290102 · Pharmacokinetic Profile and Safety of Fluticasone Propionate and Albuterol Sulfate in Combination When Compared to Fluticasone Propionate Multidose Dry Powder Inhaler (Fp MDPI) in Children Aged 4 to 11 Years OldTeva Branded Pharmaceutical Products R&D, Inc. · completed · Asthma · study director
- Ph1NCT06253546 · Safety, Tolerability, and Pharmacokinetic Study of TV-44749 in Chinese Patients With SchizophreniaTeva Branded Pharmaceutical Products R&D LLC · completed · Schizophrenia · study director
- Ph3NCT06052267 · A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma ExacerbationsTeva Branded Pharmaceutical Products R&D LLC · active not recruiting · Asthma · study director
- Ph3NCT05693935 · A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label, Long-Term Safety Phase to Evaluate the Efficacy and Safety of TV-44749 in Adults With SchizophreniaTeva Branded Pharmaceutical Products R&D LLC · completed · Schizophrenia · study director
- Ph2NCT05668013 · A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's DiseaseTeva Branded Pharmaceutical Products R&D LLC · active not recruiting · Crohn Disease, Colitis, Ulcerative · study director
- Ph2NCT05499130 · A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's DiseaseTeva Branded Pharmaceutical Products R&D, Inc. · completed · Crohn Disease, Colitis, Ulcerative · study director
- Ph3NCT05458011 · A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label Period on Efficacy and Safety of Fremanezumab in Chinese Adults With MigraineTeva Branded Pharmaceutical Products R&D, Inc. · completed · Migraine · study director
- Ph3NCT04976192 · Study to Compare Efficacy and Safety of TEV-45779 With XOLAIR (Omalizumab) in Adults With Chronic Idiopathic UrticariaTeva Pharmaceuticals USA · completed · Chronic Urticaria · study director
- Ph2NCT04847674 · A Study to Test if TEV-53275 is Effective in Relieving AsthmaTeva Branded Pharmaceutical Products R&D, Inc. · terminated · Asthma · study director
- Ph3NCT04729621 · A Study to Test if TVB-009P is Effective in Relieving Postmenopausal OsteoporosisTeva Pharmaceuticals USA · completed · Osteoporosis, Postmenopausal · study director
- Ph1NCT04682353 · A Study to Evaluate the Pharmacokinetics (PK) of Medroxyprogesterone Acetate Following an Injection of TV-46046 in Healthy Women of Reproductive AgeTeva Branded Pharmaceutical Products R&D, Inc. · completed · Contraception · study director
- Ph4NCT04677959 · A 24-Week Treatment Study to Compare Standard of Care Versus the eMDPI DS in Participants 13 Years or Older With AsthmaTeva Branded Pharmaceutical Products R&D, Inc. · completed · Asthma · study director
- Ph2NCT04545385 · A Study to Test if TEV-48574 is Effective in Relieving AsthmaTeva Branded Pharmaceutical Products R&D, Inc. · terminated · Asthma · study director
- Ph3NCT04530110 · A Trial to Test if Fremanezumab is Effective in Preventing Migraine in Children and AdolescentsTeva Branded Pharmaceutical Products R&D LLC · completed · Migraine · study director
- Ph3NCT04464707 · A Study to Test if Fremanezumab is Effective in Preventing Chronic Migraine in Participants 6 to 17 Years of AgeTeva Branded Pharmaceutical Products R&D, Inc. · completed · Migraine · study director
- Ph3NCT04458857 · A Study to Test if Fremanezumab is Effective in Preventing Episodic Migraine in Patients 6 to 17 Years of AgeTeva Branded Pharmaceutical Products R&D, Inc. · completed · Migraine · study director
- Ph2NCT04447729 · A Study to Test if Fremanezumab Reduces Pain in Patients With Interstitial Cystitis-Bladder Pain SyndromeTeva Branded Pharmaceutical Products R&D, Inc. · withdrawn · Interstitial Cystitis · study director
- Ph3NCT04200352 · A Study to Test if TEV-50717 is Safe and Effective in Relieving Abnormal Involuntary Movements in Cerebral PalsyTeva Branded Pharmaceutical Products R&D, Inc. · terminated · Cerebral Palsy, Dyskinetic · study director
- Ph4NCT04041284 · A Study to Evaluate the Efficacy and Safety of Fremanezumab for Preventive Treatment of Migraine in Patients With Major Depressive DisorderTeva Branded Pharmaceutical Products R&D, Inc. · completed · Migraine, Major Depressive Disorder · study director
- Ph2NCT03965091 · A Study to Test the Effectiveness and Safety of Fremanezumab on Participants With FibromyalgiaTeva Branded Pharmaceutical Products R&D, Inc. · terminated · Fibromyalgia · study director
- Ph3NCT03893825 · A Study to Test if TV-46000 is Safe for Maintenance Treatment of SchizophreniaTeva Branded Pharmaceutical Products R&D, Inc. · completed · Schizophrenia · study director
- Ph4NCT03890666 · A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Participants13 Years or Older With AsthmaTeva Branded Pharmaceutical Products R&D, Inc. · completed · Asthma · study director
- Ph3NCT03813238 · A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Dyskinesia in Cerebral Palsy in Children and AdolescentsTeva Branded Pharmaceutical Products R&D, Inc. · completed · Cerebral Palsy, Dyskinetic · study director
- Ph1NCT03700658 · A Study to Evaluate Injection Pain and Local Tolerability Following Subcutaneous (SC) Administration of TV-46046Teva Branded Pharmaceutical Products R&D, Inc. · completed · Contraception · study director
- Ph3NCT03571256 · A Study to Test if TEV-50717 is Effective in Relieving Tics Associated With Tourette Syndrome (TS)Teva Branded Pharmaceutical Products R&D, Inc. · completed · Tourette Syndrome · study director
- Ph3NCT03567291 · Evaluation of Safety and Tolerability of Long-term TEV-50717 (Deutetrabenazine) for Treatment of Tourette Syndrome in Children and AdolescentsTeva Branded Pharmaceutical Products R&D, Inc. · terminated · Tourette Syndrome · study director
- Ph3NCT03503318 · Study to Evaluate TV-46000 as Maintenance Treatment in Adult and Adolescent Participants With SchizophreniaTeva Branded Pharmaceutical Products R&D, Inc. · completed · Schizophrenia · study director
- Ph2/Ph3NCT03452943 · Alternatives for Reducing Tics in Tourette Syndrome (TS): A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Tourette Syndrome in Children and AdolescentsTeva Branded Pharmaceutical Products R&D, Inc. · completed · Tourette Syndrome · study director
- Ph2NCT03347188 · A Study to Test if Fremanezumab Reduces Headache in Participants With Posttraumatic Headache (PTH)Teva Branded Pharmaceutical Products R&D, Inc. · completed · Post-Traumatic Headache · study director
- Ph3NCT03308968 · An Efficacy and Safety Study of Fremanezumab in Adults With MigraineTeva Branded Pharmaceutical Products R&D, Inc. · completed · Migraine Prophylaxis · study director
- Ph3NCT03256695 · Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD)Teva Branded Pharmaceutical Products R&D, Inc. · completed · Chronic Obstructive Pulmonary Disease · study director
- Ph3NCT03107052 · A Study to Explore the Long-Term Safety and Efficacy of Fremanezumab (TEV-48125) for the Prevention of Cluster HeadacheTeva Branded Pharmaceutical Products R&D, Inc. · terminated · Cluster Headache · study director
- Ph3NCT03052725 · A Study of Reslizumab in Patients 12 Years of Age and Older With Severe Eosinophilic AsthmaTeva Branded Pharmaceutical Products R&D, Inc. · terminated · Eosinophils, Asthma · study director
- Ph3NCT03029000 · Study of the Effect of a 5-Day Regimen of Study Drug on Peripheral Stem Cell Mobilization in Healthy ParticipantsTeva Branded Pharmaceutical Products R&D, Inc. · terminated · Healthy Participants · study director
- Ph1NCT03019289 · A Study to Evaluate Sigma-1 and Dopamine-2 Receptor Occupancy by Pridopidine in the Human Brain of Healthy Volunteers and in Patients With Huntington's DiseasePrilenia · completed · Health Volunteers, Huntington Disease · study director
- Ph3NCT02980133 · Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder InhalerTeva Branded Pharmaceutical Products R&D, Inc. · completed · Asthma · study director
- Ph3NCT02969408 · A Study to Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With AsthmaTeva Branded Pharmaceutical Products R&D, Inc. · completed · Asthma · study director
- Ph3NCT02964338 · A Study Comparing the Efficacy and Safety of Fremanezumab (TEV-48125) for the Prevention of Chronic Cluster Headache (CCH)Teva Branded Pharmaceutical Products R&D, Inc. · terminated · Chronic Cluster Headache · study director
- Ph3NCT02945046 · A Study to Evaluate the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Episodic Cluster Headache (ECH)Teva Branded Pharmaceutical Products R&D, Inc. · terminated · Episodic Cluster Headache · study director
- Ph4NCT02937168 · An Imaging Study Using PET/CT to Characterize the Effect of Intravenous Reslizumab on Airway InflammationTeva Branded Pharmaceutical Products R&D, Inc. · terminated · Asthma · study director
- N/ANCT02893241 · Cafedrin/Theodrenalin (Akrinor®) Versus Ephedrine for Treatment of Hypotension in the Peri-operative Phase in Inpatient SettingRatiopharm GmbH · completed · Hypotension · study director
- Ph1NCT02817464 · Study to Evaluate Suppression of Ovulation and Pharmacokinetics of Medroxyprogesterone Acetate Following Administration of TV-46046 in Women With Ovulatory CycleTeva Branded Pharmaceutical Products R&D, Inc. · completed · Pregnancy, Contraception · study director
- N/ANCT02809989 · A Study to Evaluate the Effect of Ovaleap® on the Pregnancy Rate and Clinical Effects as Well as the User-friendliness of the Ovaleap®-Pen.Teva Pharma GmbH · completed · Pregnancy Rate, Oocytes · study director
- Ph2NCT02769091 · A Study in Adult Patients With Nonalcoholic Steatohepatitis Who Also Have Type 2 DiabetesTeva Branded Pharmaceutical Products R&D, Inc. · withdrawn · Nonalcoholic Steatohepatitis, Type 2 Diabetes Mellitus · study director
- Ph1NCT02684409 · Safety, Pharmacokinetic, and Tolerability Study of Zecuity® in Adolescent Subjects With a History of Acute MigraineNuPathe Inc. · completed · Acute Migraine · study director
- Ph1NCT02680561 · A Double Blind Open Label Comparator Study to Compare Treatments in 4 to 11 Year Old Patients With AsthmaTeva Branded Pharmaceutical Products R&D, Inc. · completed · Asthma · study director
- Ph1NCT02674321 · A Pilot Study Of SD-809 (Deutetrabenazine) In Moderate To Severe Tourette Syndrome (TS)Auspex Pharmaceuticals, Inc. · completed · TOURETTE SYNDROME · study director
- Ph1NCT02673567 · To Assess Pharmacokinetics, Safety and Tolerability of TEV-48125 in Japanese and Caucasian Healthy Subjects After a Single Subcutaneous (SC) Administration of TEV-48125Teva Branded Pharmaceutical Products R&D, Inc. · completed · Pharmacokinetics · study director
- Ph3NCT02638103 · Efficacy and Safety of Subcutaneous Administration of Fremanezumab (TEV-48125) for the Preventive Treatment of MigraineTeva Branded Pharmaceutical Products R&D, Inc. · completed · Migraine · study director
- Ph3NCT02629861 · Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic MigraineTeva Branded Pharmaceutical Products R&D, Inc. · completed · Migraine · study director
- Ph3NCT02621931 · Comparing Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of TEV-48125 Versus Placebo for the Preventive Treatment of Chronic MigraineTeva Branded Pharmaceutical Products R&D, Inc. · completed · Migraine · study director
- Ph1NCT02592031 · Study to Compare the Bioavailability, Safety and Tolerability of XM17 in Healthy, Down Regulated Young WomenMerckle GmbH · completed · Bioequivalence · study director
- Ph3NCT02513160 · Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate in Adolescent and Adult Patients 12 Years of Age and Older With Persistent AsthmaTeva Branded Pharmaceutical Products R&D, Inc. · completed · Persistent Asthma · study director
- Ph3NCT02501629 · An Efficacy and Safety Study of Reslizumab Subcutaneous in Patients With Oral Corticosteroid Dependent Asthma and Elevated Blood EosinophilsTeva Branded Pharmaceutical Products R&D, Inc. · completed · Asthma, Elevated Blood Eosinophils, Oral Corticosteroid Dependence · study director
- Ph4NCT02499900 · Study to Assess Medication Satisfaction in Patients With Relapsing Remitting Multiple Sclerosis Treated With Copaxone®Teva Branded Pharmaceutical Products R&D, Inc. · completed · Multiple Sclerosis · study director
- Ph2NCT02494778 · A Study Evaluating if Pridopidine is Safe, Efficacious, and Tolerable in Patients With Huntington's DiseasePrilenia · terminated · Huntington's Disease · study director
- Ph3NCT02487108 · Study to Evaluate the Analgesic Efficacy and Safety of Hydrocodone Bitartrate/Acetaminophen Immediate-Release Tablets in Participants With Moderate to Severe Pain Following BunionectomyTeva Branded Pharmaceutical Products R&D, Inc. · completed · Pain · study director
- Ph3NCT02452190 · Study of Reslizumab in Participants With Uncontrolled Asthma and Elevated Blood EosinophilsTeva Branded Pharmaceutical Products R&D, Inc. · completed · Asthma · study director
- Ph1NCT02437604 · Study to Determine the Pharmacokinetics and Tolerability of Fluticasone Propionate MDPI and Fluticasone Propionate/Salmeterol MDPI Compared to High Strength FLOVENT® DISKUS® and ADVAIR® DISKUS® in Patients With Persistent Asthma 12 Years of Age and OlderTeva Branded Pharmaceutical Products R&D, Inc. · completed · Asthma · study director
- N/ANCT02419872 · Study in Patients' With Persistent Asthma and Chronic Obstructive Pulmonary DiseaseTeva Pharmaceuticals Europe · completed · Asthma, Chronic Obstructive Pulmonary Disease · study director
- Ph3NCT02410343 · Study of TV-1106 in Growth Hormone-Deficient AdultsTeva Branded Pharmaceutical Products R&D, Inc. · terminated · Growth Hormone Deficiency · study director
- Ph3NCT02410356 · Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)Teva Branded Pharmaceutical Products R&D, Inc. · terminated · Growth Hormone Deficiency · study director
- N/ANCT02384577 · Study to Evaluate Satisfaction and Usability of DuoResp® SPIROMAX® in Asthma and COPD TreatmentTeva Pharma GmbH · completed · Patient Satisfaction · study director
- Ph2NCT02365636 · A Study to Evaluate the Safety and Efficacy of Topically Applied TV 45070 Ointment in Patients With Postherpetic Neuralgia (PHN)Teva Branded Pharmaceutical Products R&D, Inc. · completed · Postherpetic Neuralgia · study director
- Ph1NCT02315144 · An Efficacy and Safety Profile of Inhaled TV48108 in Healthy Volunteers and COPD PatientsTeva Branded Pharmaceutical Products R&D, Inc. · terminated · Chronic Obstructive Pulmonary Disease · study director
- Ph1NCT02315131 · Study in Healthy Volunteers and COPD Patients to Evaluate the Efficacy and Safety of Inhaled TV46017Teva Branded Pharmaceutical Products R&D, Inc. · terminated · Chronic Obstructive Pulmonary Disease (COPD · study director
- Ph1NCT02306915 · PK, PD, Safety and Tolerability of Lipegfilgrastim in Healthy Japanese and Caucasian ParticipantsMerckle GmbH · completed · Pharmacokinetics, Pharmacodynamics · study director
- Ph3NCT02291861 · Addressing Involuntary Movements in Tardive DyskinesiaAuspex Pharmaceuticals, Inc. · completed · Tardive Dyskinesia · study director
- Ph2NCT02284568 · A Phase 2 Clinical Study in Subjects With Primary Progressive Multiple Sclerosis to Assess the Efficacy, Safety and Tolerability of Two Oral Doses of Laquinimod Either of 0.6 mg/Day or 1.5mg/Day (Experimental Drug) as Compared to PlaceboTeva Branded Pharmaceutical Products R&D, Inc. · completed · Primary Progressive Multiple Sclerosis · study director
- Ph1NCT02215941 · Study to Characterize the Pharmacokinetics and Safety of TV-45070 Ointment in Healthy VolunteersTeva Branded Pharmaceutical Products R&D, Inc. · completed · Pharmacokinetics · study director
- Ph2NCT02203474 · A Study of 3 Doses of Tiotropium Hydrofluoralkane (HFA) Breath Actuated Inhaler (BAI), in Patients With Chronic Obstructive Pulmonary DiseaseTeva Branded Pharmaceutical Products R&D, Inc. · withdrawn · Chronic Obstructive Pulmonary Disease, COPD · study director
- Ph1NCT02202005 · Multiple Dose BE Study With Nevirapine 400mg PR TabletsRatiopharm GmbH · completed · HIV-1 · principal investigator
- Ph2NCT02190721 · A Study to Evaluate 5 μg/kg Tbo-filgrastim in Infants, Children and Adolescents With Solid Tumors Without Bone Marrow InvolvementTeva Branded Pharmaceutical Products R&D, Inc. · completed · Neutropenia · study director
- Ph3NCT02175771 · Long-Term Safety Study of Fluticasone Propionate (Fp) Multidose Dry Powder Inhaler (MDPI) and Fluticasone Propionate/Salmeterol (FS) MDPI in Patients With Persistent AsthmaTeva Branded Pharmaceutical Products R&D, Inc. · completed · Persistent Asthma · study director
- Ph3NCT02141854 · Efficacy and Safety Study of FP MDPI Compared With FS MDPI in Adolescent and Adult Patients With Persistent AsthmaTeva Branded Pharmaceutical Products R&D, Inc. · completed · Asthma · study director
- Ph3NCT02139644 · Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent AsthmaTeva Branded Pharmaceutical Products R&D, Inc. · completed · Asthma · study director
- Ph1NCT02085863 · A Phase I Study in Young Healthy Women to Investigate the Effects of Laquinimod on Standard Oral Contraceptive When Both Treatments Are Given TogetherTeva Branded Pharmaceutical Products R&D, Inc. · completed · Pharmacokinetics, Pharmacodynamics · study director
- Ph3NCT02062463 · Study to Evaluate the Mastery of Inhaler Technique for Budesonide Formoterol (BF) SPIROMAX® as Compared to SYMBICORT® TURBOHALER® as Treatment for Adult Participants With AsthmaTeva Branded Pharmaceutical Products R&D, Inc. · completed · Asthma · study director
- Ph3NCT02044276 · A comparatiVe Study on Efficacy and Safety of Lipegfilgrastim in Comparison to Pegfilgrastim in Elderly Patients With Aggressive B Cell Non-HOdgkin Lymphomas at hIgh Risk for R-CHOP-21-inDuced NeutropeniaTeva Branded Pharmaceutical Products R&D, Inc. · completed · Aggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced Neutropenia · study director
- Ph3NCT02040766 · A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants Ages 4-11 Years Old With Persistent AsthmaTeva Branded Pharmaceutical Products R&D, Inc. · completed · Asthma · study director
- Ph3NCT02031640 · A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent AsthmaTeva Branded Pharmaceutical Products R&D, Inc. · completed · Asthma · study director
- Ph2NCT02025556 · A Multicenter Assessment of LBR-101 in High Frequency Episodic MigraineTeva Branded Pharmaceutical Products R&D, Inc. · completed · Episodic Migraine Headache · study director
- Ph2NCT02021773 · Assessment of LBR-101 In Chronic MigraineTeva Branded Pharmaceutical Products R&D, Inc. · completed · Chronic Migraine · study director
- Ph3NCT01922739 · Open-Label, Extension Study to Evaluate the Safety of Hydrocodone Bitartrate Extended-Release TabletsTeva Branded Pharmaceutical Products R&D, Inc. · completed · Low Back Pain · study director
- Ph3NCT01897896 · Alternatives for Reducing Chorea in Huntington DiseaseAuspex Pharmaceuticals, Inc. · completed · Chorea Associated With Huntington Disease · study director
- Ph3NCT01707992 · The Efficacy, Safety, and Tolerability of Laquinimod in Participants With Relapsing Remitting Multiple Sclerosis (RRMS)Teva Branded Pharmaceutical Products R&D, Inc. · completed · Multiple Sclerosis · study director
- Ph1NCT01624480 · Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With NarcolepsyTeva Branded Pharmaceutical Products R&D, Inc. · completed · Narcolepsy · study director
- Ph3NCT01596621 · A Study of Bendamustine in the Treatment of Chinese Participants With Indolent Non-Hodgkin Lymphoma Refractory to Rituximab TreatmentTeva Branded Pharmaceutical Products R&D, Inc. · completed · Non-Hodgkin Lymphoma · study director
- Ph3NCT01126190 · Neugranin in Breast Cancer Participants Receiving Doxorubicin/DocetaxelTeva Branded Pharmaceutical Products R&D, Inc. · completed · Chemotherapy-induced Neutropenia · study director
- Ph2/Ph3NCT00837265 · Balugrastim (Neugranin) in Breast Cancer Participants Receiving Doxorubicin/DocetaxelTeva Branded Pharmaceutical Products R&D, Inc. · completed · Chemotherapy-induced Neutropenia · study director
- Ph3NCT00665223 · A Study of Treatment With Pridopidine (ACR16) in Participants With Huntington's DiseaseTeva Branded Pharmaceutical Products R&D, Inc. · completed · Huntington's Disease · study director
- Ph4NCT00530062 · Comparison of Single-Dose Efficacy of an Albuterol Breath-Actuated Inhaler (Albuterol-HFA-BAI) Versus an Albuterol Metered-Dose Inhaler (Albuterol-HFA-MDI) in Participants With AsthmaTeva Branded Pharmaceutical Products R&D, Inc. · completed · Asthma · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:32 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.